LP429468-4CariprazineActive
Description
LP429468-4 Cariprazine
Cariprazine is one of the newest dopamine-serotonin partial agonists, also known as 'atypical' second generation antipsychotics. Originally approved for acute and maintenance treatment of schizophrenia as well as for acute mania and mixed mania/depression, cariprazine has now been approved for bipolar I depression. [PMID:32110377]
Source: LOINC
Basic Part Properties
- Name
- Cariprazine
- Type
- Component
- Created On
- 2021-09-03
- Construct for LOINC Short Name
- Cariprazine
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP429468-4
Language Variants Get Info
- zh-CNChinese (China)
- 卡比米嗪
Synonyms: CAS 839712-12-8;卡利拉嗪; Vraylar; 新型候选抗精神病药物; 试验性非典型抗精神病用药, 用于精神分裂症患者和双相Ⅰ型障碍相关的躁狂或混合发作患者 - nl-NLDutch (Netherlands)
- cariprazine
- it-ITItalian (Italy)
- Cariprazina
- es-ESSpanish (Spain)
- Cariprazina
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright